Operating through 360 independent affiliates in 140 countries, Novartis offers its products and services through its Pharmaceuticals, Oncology, Vaccines, Animal Health, Consumer Health, Sandoz and Alcon divisions. One of the world’s leading healthcare companies, Novartis’ dedication to scientific research, imagination, and new technologies has led to the creation of thousands of groundbreaking products and services in the areas of pharmaceuticals, nutrition, eye-care, vaccine, and animal health. That dedication is reflected in our name — Novartis — which is derived from the Latin, novae artes, signifying new skills. It reflects our drive to be on the leading edge of the healthcare industry, a visionary company with a “product pipeline” filled with remarkable breakthroughs.

Over the past decade, Novartis Pharmaceuticals Canada has introduced 20 new medicines that have had an important impact on patients suffering from a wide variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation and osteoporosis.